NFKB1 and atherosclerosis: “Tricyclic antidepressants”, “Atherosclerosis”, “Inflammatory pathways”, “NF-κB activation”, “TLRs”, “Adiponectin”, “Cytokines”, and “Endothelial dysfunction”.